Compounds > 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate
Page last updated: 2024-08-26

3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate and Substance Withdrawal Syndrome

3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate has been researched along with Substance Withdrawal Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ho, IK; Kimura, T; Miyaoka, T; Saunders, PA; Tseng, YT1

Other Studies

1 other study(ies) available for 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate and Substance Withdrawal Syndrome

ArticleYear
Binding characteristics of [3H]flunitrazepam in pentobarbital-withdrawal rats.
    Neurochemical research, 1994, Volume: 19, Issue:1

    Topics: Animals; Cell Membrane; Cerebral Ventricles; Chlorides; Cholic Acids; Flunitrazepam; Frontal Lobe; Infusions, Parenteral; Kinetics; Male; Pentobarbital; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Substance Withdrawal Syndrome; Tritium

1994